All In MedTech

FDA Clearance Tracker · P150048-S012

Edwards Pericardial Mitral Bioprosthesis, Model 11000M

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Aug 9, 2018 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Aug 9, 2018

Approved

Time to decision

251 days

Received Dec 1, 2017. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Panel Track

Device class

Class III

The decision

FDA number
P150048-S012
Device name
Edwards Pericardial Mitral Bioprosthesis, Model 11000M
Applicant location
Irvine, CA
Received
Dec 1, 2017
Decided
Aug 9, 2018
Decision
Approved
Supplement type
Panel Track
Reason for supplement
Labeling Change - Indications/instructions/shelf life/tradename
Original approval
P150048

Device type

Device class
Class III

Every decision under product code LWR

FDA's approval statement

As written in FDA's record.

Approval for the Edwards Pericardial Mitral Bioprosthesis, Model 11000M. This device is indicated for the replacement of native or prosthetic mitral heart valves.

Source documents

Other decisions for Edwards Lifesciences, LLC

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.